266 related articles for article (PubMed ID: 36372873)
21. ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach.
Nielsen LR; Stensgaard S; Meldgaard P; Sorensen BS
Cancer Treat Res Commun; 2024; 39():100802. PubMed ID: 38428066
[TBL] [Abstract][Full Text] [Related]
22. Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study.
Kang G; Chen K; Yang F; Chuai S; Zhao H; Zhang K; Li B; Zhang Z; Wang J
BMC Cancer; 2019 Jun; 19(1):579. PubMed ID: 31195991
[TBL] [Abstract][Full Text] [Related]
23. Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer.
Tolmeijer SH; van Wilpe S; Geerlings MJ; von Rhein D; Smilde TJ; Kloots ISH; Westdorp H; Coskuntürk M; Oving IM; van Ipenburg JA; van der Heijden AG; Hofste T; Weiss MM; Schalken JA; Gerritsen WR; Ligtenberg MJL; Mehra N
Eur Urol Oncol; 2024 Apr; 7(2):282-291. PubMed ID: 37673768
[TBL] [Abstract][Full Text] [Related]
24. Efficient detection and monitoring of pediatric brain malignancies with liquid biopsy based on patient-specific somatic mutation screening.
Kojic M; Maybury MK; Waddell N; Koufariotis LT; Addala V; Millar A; Wood S; Pearson JV; Hansford JR; Hassall T; Wainwright BJ
Neuro Oncol; 2023 Aug; 25(8):1507-1517. PubMed ID: 36757207
[TBL] [Abstract][Full Text] [Related]
25. Postoperative ctDNA in indicating the recurrence risk and monitoring the effect of adjuvant therapy in surgical non-small cell lung cancer.
Tian X; Liu X; Wang K; Wang R; Li Y; Qian K; Wang T; Zhao X; Liu L; Zhang PL; Xiong Y; Rui J; Chen R; Zhang Y
Thorac Cancer; 2024 Apr; 15(10):797-807. PubMed ID: 38409945
[TBL] [Abstract][Full Text] [Related]
26. The Utility of ctDNA in Lung Cancer Clinical Research and Practice: A Systematic Review and Meta-Analysis of Clinical Studies.
Sun X; Abrahamson P; Ballew N; Kalilani L; Phiri K; Bell KF; Slowley A; Zajac M; Hofstatter E; Stojadinovic A; Silvestro A; Wang Z; Aziez A; Peters S
Cancer Invest; 2023 Jul; 41(6):571-592. PubMed ID: 37272675
[TBL] [Abstract][Full Text] [Related]
27. Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer.
Stensgaard S; Thomsen A; Helstrup S; Meldgaard P; Sorensen BS
Transl Lung Cancer Res; 2023 May; 12(5):971-984. PubMed ID: 37323168
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.
Pellini B; Madison RW; Childress MA; Miller ST; Gjoerup O; Cheng J; Huang RSP; Krainock M; Gupta P; Zou W; Shames DS; Moshkevich S; Ballinger M; Liu MC; Young A; Srivastava MK; Oxnard GR; Socinski MA
Clin Cancer Res; 2023 Nov; 29(22):4596-4605. PubMed ID: 37702716
[TBL] [Abstract][Full Text] [Related]
29. The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis.
Di WY; Chen YN; Cai Y; Geng Q; Tan YL; Li CH; Wang YN; Shang YH; Fang C; Cheng SJ
Front Neurol; 2023; 14():1076310. PubMed ID: 36937524
[TBL] [Abstract][Full Text] [Related]
30. Liquid biopsy in the setting of leptomeningeal metastases: a systematic review and meta-analysis.
Wijaya JH; Patel UD; Quintero-Consuegra MD; Aguilera-Peña MP; Madriñán-Navia HJ; Putra AW; July J; Kataria S
J Neurooncol; 2023 Dec; 165(3):431-438. PubMed ID: 38019327
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer.
Lee DW; Lim Y; Kim HP; Kim SY; Roh H; Kang JK; Lee KH; Kim MJ; Ryoo SB; Park JW; Jeong SY; Park KJ; Kang GH; Han SW; Kim TY
Cancer Res Treat; 2023 Jul; 55(3):927-938. PubMed ID: 36915247
[TBL] [Abstract][Full Text] [Related]
32. Liquid biopsy for pediatric diffuse midline glioma: a review of circulating tumor DNA and cerebrospinal fluid tumor DNA.
Azad TD; Jin MC; Bernhardt LJ; Bettegowda C
Neurosurg Focus; 2020 Jan; 48(1):E9. PubMed ID: 31896079
[TBL] [Abstract][Full Text] [Related]
33. Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.
Mangum R; Reuther J; Sen Baksi K; Gandhi I; Zabriskie RC; Recinos A; Raesz-Martinez R; Lin FY; Potter SL; Sher AC; Kralik SF; Mohila CA; Chintagumpala MM; Muzny D; Hu J; Gibbs RA; Fisher KE; Bernini JC; Gill J; Griffin TC; Tomlinson GE; Vallance KL; Plon SE; Roy A; Parsons DW
Pediatr Hematol Oncol; 2023; 40(8):719-738. PubMed ID: 37366551
[TBL] [Abstract][Full Text] [Related]
34. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
Jee J; Lebow ES; Yeh R; Das JP; Namakydoust A; Paik PK; Chaft JE; Jayakumaran G; Rose Brannon A; Benayed R; Zehir A; Donoghue M; Schultz N; Chakravarty D; Kundra R; Madupuri R; Murciano-Goroff YR; Tu HY; Xu CR; Martinez A; Wilhelm C; Galle J; Daly B; Yu HA; Offin M; Hellmann MD; Lito P; Arbour KC; Zauderer MG; Kris MG; Ng KK; Eng J; Preeshagul I; Victoria Lai W; Fiore JJ; Iqbal A; Molena D; Rocco G; Park BJ; Lim LP; Li M; Tong-Li C; De Silva M; Chan DL; Diakos CI; Itchins M; Clarke S; Pavlakis N; Lee A; Rekhtman N; Chang J; Travis WD; Riely GJ; Solit DB; Gonen M; Rusch VW; Rimner A; Gomez D; Drilon A; Scher HI; Shah SP; Berger MF; Arcila ME; Ladanyi M; Levine RL; Shen R; Razavi P; Reis-Filho JS; Jones DR; Rudin CM; Isbell JM; Li BT
Nat Med; 2022 Nov; 28(11):2353-2363. PubMed ID: 36357680
[TBL] [Abstract][Full Text] [Related]
35. Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study.
Walls GM; McConnell L; McAleese J; Murray P; Lynch TB; Savage K; Hanna GG; de Castro DG
Radiat Oncol; 2020 May; 15(1):132. PubMed ID: 32471446
[TBL] [Abstract][Full Text] [Related]
36. [Advances in Clinical Application of Cerebrospinal Fluid Circulating Tumor DNA
in Leptomeningeal Metastasis of Non-small Cell Lung Cancer].
Li Y; Li X
Zhongguo Fei Ai Za Zhi; 2024 May; 27(5):376-382. PubMed ID: 38880925
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis.
Lu J; Feng Y; Guo K; Sun L; Ruan S; Zhang K
J Cancer Res Clin Oncol; 2024 Jan; 150(1):25. PubMed ID: 38252173
[TBL] [Abstract][Full Text] [Related]
38. Mutational evolution after chemotherapy-progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis.
Kim S; Cha Y; Lim Y; Roh H; Kang JK; Lee KH; Kim MJ; Park JW; Ryoo SB; Kim HP; Jeong SY; Park KJ; Han SW; Kim TY
Int J Cancer; 2023 Aug; 153(3):571-583. PubMed ID: 37194418
[TBL] [Abstract][Full Text] [Related]
39. Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
Li M; Chen J; Zhang B; Yu J; Wang N; Li D; Shao Y; Zhu D; Liang C; Ma Y; Ou Q; Hou X; Chen L
BMC Med; 2023 Jan; 21(1):15. PubMed ID: 36617568
[No Abstract] [Full Text] [Related]
40. Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study.
Liu W; Jin KM; Zhang MH; Bao Q; Liu M; Xu D; Wang K; Xing BC
Ann Surg Oncol; 2023 Aug; 30(8):4916-4926. PubMed ID: 37219651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
